Tyra Biosciences
Edit

Tyra Biosciences

https://tyra.bio/
Last activity: 02.02.2024
Categories: DrugLifeDevelopmentSmartBioTechActiveDesign
Tyra Biosciences is an Alta-incubated biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.Tyra is combining insights from structure-based drug design (SBDD), kinase biology, computational chemistry and smart clinical development to discover and develop next-gen small molecule therapies that are active against both wild type and mutant targets
Mentions
31
Location: United States, California, Carlsbad
Employees: 11-50
Total raised: $356M
Founded date: 2018

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
02.02.2024-$200M-
31.03.2021-$106M-
28.01.2020Series A$50M-

Mentions in press and media 31

DateTitleDescriptionSource
02.02.2024 Tyra Bioscienes Scores $200M In PIPE Carlsbad-based Tyra Biosciences ,a company developing precision medicines for targeting Fibroblast G...socaltech....
03.11.2021Tyra Biosciences Reports Third Quarter 2021 Financial Result...CARLSBAD, Calif., Nov. 3, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision on...marketscre...
14.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
13.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
11.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
10.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
09.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
08.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
07.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
03.10.2021Tyra Biosciences closes IPO for $172.8M-connect.or...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In